BioWorld A closer look BioWorld Asia BioWorld Science

BioWorld

Flexibility restored? Uniqure plans for BLA filing in Huntington’s
Another day, another about-face by the U.S. FDA on Uniqure NV’s Huntington’s disease gene therapy. But this latest shift brings good news for the company’s AMT-130, for...

More in BioWorld

BioWorld Science

mRNA flu vaccine can activate broad germinal center response
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers at...

More in BioWorld Science

A closer look

Ongoing coverage of the Ebola outbreak
Stay up to date as BioWorld reports on the latest developments of the Ebola virus public health emergency.

More in A closer look

BioWorld Asia

China clears Alphamab’s HER2 bispecific antibody in gastric cancer
China’s National Medical Products Administration has approved Suzhou Alphamab Co. Ltd.’s HER2 bispecific antibody, anbenitamab (KN-026), through priority review for adults...

More in BioWorld Asia

BioWorld Insider podcast

The opioid crisis may not be front and center anymore, but it’s raging still. Elysium Therapeutics Inc. CEO Greg Sturmer talks about his firm’s candidate for a solution to the medical and societal problem.